Some Hospitals Abandoning Use of Morcellators Following FDA Danger Warnings

Following FDA warnings about the cancer risk, a growing number of hospitals and medical institutions are abandoning the devices during laparoscopic hysterectomy procedures and uterine fibroid removal surgeries, due to concerns that they spread undiagnosed sarcomas throughout the pelvis and abdomen.

On Wednesday, Cleveland Clinic and the University of Pennsylvania Health System were the latest leading institutions to announce that morcellators will no longer be used for uterine fibroid treatments during a hysterectomy or myomectomy. The hospitals follow Brigham and Women’s Hospital and Massachusetts General Hospital, who made similar decisions earlier this month.


Get a Free Consultation

Contact Us Today!
    • Please enter your name.
    • This isn't a valid phone number.
      Please enter your phone number.
    • This isn't a valid email address.
      Please enter your email address.
    • Please make a selection.
  • Please enter a message.
    • I have read the disclaimer.

      Please read and agree to the disclaimer

      The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.